Moreover, our laboratory reported that promotion of β-arrestin-2 signaling via the action of biased ligands at the AT1R was able to reverse these maladaptive changes in a genetic model of heart failure with dilated cardiomyopathy (DCM; Ryba et al., 2017). This evidence concerns the gene AGTR1 and dilated cardiomyopathy.